Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia

被引：32

作者：

Nishio, M

Endo, T

Fujimoto, K

Sato, N

Sakai, T

Obara, M

Kumano, K

Minauchi, K

Koike, T

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Med 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan

[2] Hokkaido Univ Hosp, Blood Transfus Serv, Sapporo, Hokkaido 060, Japan

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2005年 / 75卷 / 06期

关键词：

D O I：

10.1111/j.1600-0609.2005.00552.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：527 / 529

页数：3

共 10 条

[1] Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient [J].

Endo, T ;

Nakao, S ;

Koizumi, K ;

Nishio, M ;

Fujimoto, K ;

Sakai, T ;

Kumano, K ;

Obara, M ;

Koike, T .

ANNALS OF HEMATOLOGY, 2004, 83 (02) :114-116

[2] Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma [J].

Horwitz, SM ;

Negrin, RS ;

Blume, KG ;

Breslin, S ;

Stuart, MJ ;

Stockerl-Goldstein, KE ;

Johnston, LJ ;

Wong, RM ;

Shizuru, JA ;

Horning, SJ .

BLOOD, 2004, 103 (03) :777-783

[3] Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease [J].

Imashuku, S ;

Teramura, T ;

Morimoto, A ;

Naya, M ;

Kuroda, H .

BONE MARROW TRANSPLANTATION, 2004, 33 (01) :129-130

[4] CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation [J].

Kuehnie, I ;

Huls, MH ;

Liu, ZS ;

Semmelmann, M ;

Krance, RA ;

Brenner, MK ;

Rooney, CM ;

Heslop, HE .

BLOOD, 2000, 95 (04) :1502-1505

[5]

Maloney DG, 1997, BLOOD, V90, P2188

[6] Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma [J].

Miles, SA ;

McGratten, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :247-248

[7] Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure [J].

Nishio, M ;

Nakao, S ;

Endo, T ;

Fujimoto, K ;

Takashima, H ;

Sakai, T ;

Bacigalupo, A ;

Koike, T ;

Sawada, K .

BONE MARROW TRANSPLANTATION, 2001, 28 (08) :783-785

[8] Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects [J].

Piqueras, B ;

Lavenu-Bombled, C ;

Galicier, L ;

Bergeron-Van der Cruyssen, F ;

Mouthon, L ;

Chevret, S ;

Debré, P ;

Schmitt, C ;

Oksenhendler, E .

JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (05) :385-400

[9] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma [J].

Shimoni, A ;

Hardan, I ;

Avigdor, A ;

Yeshurun, M ;

Raanani, P ;

Ben-Bassat, I ;

Nagler, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) :457-464

[10] Treatment of posttransplant lymphoproliferatieve disease with rituximab: The remission, the relapse, and the complication [J].

Verschuuren, EAM ;

Stevens, SJC ;

Van Imhoff, GW ;

Middeldorp, JM ;

De Boer, C ;

Koeter, G ;

The, TH ;

Van Der Bij, W .

TRANSPLANTATION, 2002, 73 (01) :100-104

← 1 →